TY - JOUR
T1 - IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility
AU - Nguyen, Hai Ha
AU - Takata, Ryo
AU - Akamatsu, Shusuke
AU - Shigemizu, Daichi
AU - Tsunoda, Tatsuhiko
AU - Furihata, Mutsuo
AU - Takahashi, Atsushi
AU - Kubo, Michiaki
AU - Kamatani, Naoyuki
AU - Ogawa, Osamu
AU - Fujioka, Tomoaki
AU - Nakamura, Yusuke
AU - Nakagawa, Hidewaki
N1 - Funding Information:
We are also grateful to the members of the BioBank Japan project and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government, and was supported in part by Research grant #22390306 (H.N.) from the Japan Society for the Promotion of Science and by the Princess Takamatsu Cancer Research Fund and Takeda Science Foundation.
PY - 2012/5
Y1 - 2012/5
N2 - Recent genome-wide association studies (GWAS) identified a number of prostate cancer (PC) susceptibility loci, but most of their functional significances are not elucidated. Through our previous GWAS for PC in a Japanese population and subsequent resequencing and fine mapping, we here identified that IRX4 (Iroquois homeobox 4), coding Iroquois homeobox 4, is a causative gene of the PC susceptibility locus (rs12653946) at chromosome 5p15. IRX4 is expressed specifically in the prostate and heart, and quantitative expression analysis revealed a significant association between the genotype of rs12653946 and IRX4 expression in normal prostate tissues. Knockdown of IRX4 in PC cells enhanced their growth and IRX4 overexpression in PC cells suppressed their growth, indicating the functional association of IRX4 with PC and its tumor suppressive effect. Immunoprecipitation confirmed its protein-protein interaction to vitamin D receptor (VDR), and we found a significant interaction between IRX4 and VDR in their reciprocal transcriptional regulation. These findings indicate that the PC-susceptibility locus represented by rs12653946 at 5p15 is likely to regulate IRX4 expression in prostate which could suppress PC growth by interacting with the VDR pathway, conferring to PC susceptibility.
AB - Recent genome-wide association studies (GWAS) identified a number of prostate cancer (PC) susceptibility loci, but most of their functional significances are not elucidated. Through our previous GWAS for PC in a Japanese population and subsequent resequencing and fine mapping, we here identified that IRX4 (Iroquois homeobox 4), coding Iroquois homeobox 4, is a causative gene of the PC susceptibility locus (rs12653946) at chromosome 5p15. IRX4 is expressed specifically in the prostate and heart, and quantitative expression analysis revealed a significant association between the genotype of rs12653946 and IRX4 expression in normal prostate tissues. Knockdown of IRX4 in PC cells enhanced their growth and IRX4 overexpression in PC cells suppressed their growth, indicating the functional association of IRX4 with PC and its tumor suppressive effect. Immunoprecipitation confirmed its protein-protein interaction to vitamin D receptor (VDR), and we found a significant interaction between IRX4 and VDR in their reciprocal transcriptional regulation. These findings indicate that the PC-susceptibility locus represented by rs12653946 at 5p15 is likely to regulate IRX4 expression in prostate which could suppress PC growth by interacting with the VDR pathway, conferring to PC susceptibility.
UR - http://www.scopus.com/inward/record.url?scp=84859227397&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859227397&partnerID=8YFLogxK
U2 - 10.1093/hmg/dds025
DO - 10.1093/hmg/dds025
M3 - Article
C2 - 22323358
AN - SCOPUS:84859227397
SN - 0964-6906
VL - 21
SP - 2076
EP - 2085
JO - Human molecular genetics
JF - Human molecular genetics
IS - 9
M1 - dds025
ER -
